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Background: Surgery remains the main treatment for locally advanced thyroid cancers invading the trachea,
esophagus, and recurrent laryngeal nerve. However, extensive resection of such tumors can sometimes involve
difficulties and may result in the deterioration of the patient’s quality of life. The surgeon should consider not only
the patient’s prognosis but also the preservation of postoperative function.
Methods: This report describes a minimally invasive surgical procedure for recurrent poorly differentiated papillary
thyroid carcinoma involving the trachea and esophagus. To decrease the potential for recurrent laryngeal nerve
injuries and to preserve both the tracheal and esophageal blood supply, we adapted a transtracheal approach; the
recurrent tumor was safely and completely removed without causing a dysfunction. After a tracheotomy to the
right, the tumor was easily detected through the tracheostoma and delineated by palpation. The mucous
membrane of the trachea was minimally incised along the right-hand border of the tumor and a mucosal flap was
elevated. The left side of the trachea including the membranous wall and cartilage of the tracheal mucosa was
maximally preserved, to maintain the vascular supply to the trachea. Finally, the membranous wall of the trachea
was preserved to within one-third of the left-hand side. Furthermore, the risk of bleeding from major lateral vessels
was reduced. A sternocleidomastoid muscle flap was elevated and inserted into the cavity resulting from the tumor
resection and sutured between the esophagus and trachea. The membranous wall of the tracheal mucosa was also
sutured submucosally.
Results: The tumor was removed completely with the muscular layer of the esophagus without injury to the intact
recurrent laryngeal nerve and lateral major vessels. The patient started oral nutritional intake on the first postoperative
day and was discharged without any significant postoperative complications.
Conclusions: This new procedure for transtracheal resection for recurrent thyroid cancer involving the trachea and
esophagus was useful and safe.
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Surgery remains the mainstay for the treatment of
locally advanced recurrent thyroid cancer. However, with
complex recurrent thyroid cancer with recurrent laryn-
geal nerve palsy, dissection for the trachea and eso-
phagus can be associated with significant morbidity,
including dyspnea and dysphagia [1,2]. The morbidity
from radical resection has led some surgeons to avoid
curative treatments. Our objective was to perform
minimally invasive surgery with transtracheal central
neck dissection for recurrent thyroid cancer. The key
point of this technique was to complete the procedure
with potentially less risk of injury to the intact recur-
rent laryngeal nerve or the lateral major vessels. To
our knowledge, there have been no reports regarding




A 69-year-old woman with a past surgical history for a
poorly differentiated thyroid cancer presented with a
2 × 2 cm mass between the trachea and the esophagus.
The patient already had right recurrent laryngeal palsy
from the first treatment. This recurrence was detected by
computed tomography (CT), and was shown to be rapidly
enlarging over the course of two months (Figure 1). The
lesion was also examined by fluorodeoxyglucose (FDG)
positron emission tomography (PET), which showed
high FDG uptake (maximum standardized uptake value,
15.45) and demonstrated a recurrence of thyroid cancer
(Figure 2). After providing written informed consent,
the patient underwent surgical resection of the recur-
rent thyroid cancer with the new procedure. The patient
was positioned under general anesthesia in a supine pos-
ition on the operating table with her neck hyperextended.Figure 1 CT of neck with contrast medium, showing heterogeneous e
(B) sagittal section.Through a transverse cervical incision made just along the
previous surgical scar, a tracheotomy was performed. The
tumor was easily detected through the tracheostoma, then
delineated by palpation. The mucous membrane of the
trachea was minimally incised along the right-hand border
of the tumor and a mucosal flap was elevated (Figure 3).
The left-hand side of the trachea including the membran-
ous wall and cartilage of the tracheal mucosa was max-
imally preserved, to maintain the vascular supply to the
trachea. Finally, the membranous wall of the trachea
was preserved to within one-third of the left-hand side
(Figure 4A). Bleeding from both cut edges of the tracheal
mucosa was confirmed. There was no extracapsular
spread and the tumor was removed completely with the
muscular layer of the esophagus. Intraoperative frozen
examination revealed that the tumor was completely
resected. A right sternocleidomastoid muscle flap was ele-
vated and inserted into the cavity resulting from the tumor
resection and sutured between the esophagus and the tra-
chea. The membranous wall of the tracheal mucosa was
also sutured submucosally. A temporary tracheocutaneous
stoma was made.
Results
The tumor was removed completely with the muscular
layer of the esophagus without injuring the intact recur-
rent laryngeal nerve and lateral major vessels. The total
surgical time was 170 minutes with 30 ml blood loss. All
the removed tissues were sent for histopathologic evalu-
ation, and were found to be consistent with poorly
differentiated thyroid carcinoma (Figure 2B). The patient
started oral nutritional intake on the first postoperative
day, and she was discharged on the seventh postopera-
tive day. The patient did not experience any significant
postoperative complications, such as dysphagia. By the
3-month follow-up, the healing of the intratrachealnhanced mass between trachea and esophagus. (A) axial section;
Figure 2 PET/CT and pathological findings. (A) Axial view of PET/CT study shows the recurrent tumor mass between the trachea and esophagus
with high uptake of FDG at a peak standardized uptake value of 15.45. (B) Low-power magnification; arrow shows extracapsular extension.
(C) High-power magnification. Pathological findings demonstrate poorly differentiated thyroid carcinoma.
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be seen (Figure 4B). The tracheostoma was closed under
local anesthesia. The patient has been alive with no evi-
dence of recurrence for 5 postoperative years.
Discussion
Poorly differentiated thyroid carcinoma is a group of
carcinomas that exists between well differentiated and
anaplastic thyroid carcinoma in terms of both morpho-
logical appearance and biological behavior [3,4]. The
World Health Organization classification of endocrineFigure 3 Intraoperative findings. (A) The tumor was detected just under
wall of the trachea. (B) The tumor was resected with minimal additional in
tumor from between the membranous portion of the retracted trachea antumors separately categorized poorly differentiated and
well differentiated thyroid carcinoma in 2004. In 2006,
the Turin proposal for an algorithm for the diagnosis of
poorly differentiated carcinomas recommended that it
be defined as the presence of a solid, trabecular, or insu-
lar growth pattern but with the absence of the conven-
tional nuclear features of papillary carcinoma [5,6]. The
principal treatment for this entity is surgical manage-
ment. However, bilateral recurrent laryngeal palsy is
easily caused by surgical procedures, such as heat
resulting from electrocautery or traction used to watchthe tracheal mucosa. Dashed circle: tumor behind the membranous
cision of the membranous wall of the trachea. Arrow: pulling out the
d the esophagus.
Figure 4 Surgical procedure and postoperative endotracheal finding. (A) Surgical procedure. (B) Endotracheal finding 3 months after the
surgery. There is no granulation formation. Arrow indicates the left-hand end of the surgical scar on the membranous wall of the trachea.
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sis is a serious disease, causing life-threatening respira-
tory distress or swallowing dysfunction. Moreover, a
tracheal anastomotic leak potentially causes painful
dyspnea resulting from mediastinal emphysema. Since
significant morbidities and poor quality of life may
result from surgical procedures for recurrent cancer
involving the trachea and esophagus, a minimally inva-
sive procedure is needed. However, it was challenging
for us to establish an ideal surgical strategy for recur-
rent thyroid cancer with unilateral vocal cord paralysis.
To reduce morbidities associated with extensive resec-
tion and to decrease the potential for bilateral recurrent
nerve injury, we adopted an endoluminal approach. The
approach through a tracheostoma enables the surgeon
to identify the tumor site with ease and without causing
recurrent laryngeal nerve injury. There is less risk of
bleeding from major lateral vessels, or of injuries to the
recurrent laryngeal nerves. The disadvantages of the
procedure include the need for a temporary tracheos-
tomy and the possibility of granulation. To avoid tra-
cheal granulation, we sutured the tracheal mucosa
submucosally. As a result, there was no granulation of
the trachea at all.
The best-known minimally invasive surgical procedure is
natural orifice transluminal endoscopic surgery (NOTES),
which does not require incision of the skin [7]. Several
studies have demonstrated the feasibility of transoral thy-
roidectomy and parathyroidectomy in animal models [8,9].
Regarding transtracheal surgery, the feasibility of transtra-
cheal evaluation of the pleural cavity using the NOTES
procedure and endoluminal repair of the membranous tra-
cheal disruptions has been reported [10]. However, there
has been no report in the literature of transluminal surgeryfor head and neck lesions. Transtracheal surgery is a modi-
fication of the NOTES technique and a feasible option for
tumors around the central neck structures. The morbidity
from extensive resection for patients with thyroid cancer
has led to a poor quality of life. To reduce complications
and preserve postoperative function, we recommend trans-
tracheal central neck dissection for recurrent thyroid can-
cers involving the trachea and esophagus to avoid injuries
to the lateral major vessels or recurrent laryngeal nerves.
Conclusion
The new procedure of transtracheal resection for recur-
rent thyroid cancer involving the trachea and esophagus
was useful and safe.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
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